Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-03-19
2004-05-18
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S341100
Reexamination Certificate
active
06737434
ABSTRACT:
TECHNICAL FIELD
The present invention relates to novel imidazole derivatives exhibiting cytokine-like activities; in particular, activities analogous to those exhibited by granulocyte-colony stimulating factor (hereinafter referred to as “G-CSF”).
BACKGROUND ART
G-CSF drugs have been found effective in therapy of immune diseases which accompany reduction in neutrophils caused by chemotherapy or radiotherapy of cancer. In clinical settings, a human gene recombinant G-CSF injection (Sankyo Co., Ltd.) or similar products are currently employed as G-CSF drugs. However, the G-CSF injection involves drawbacks; namely, it produces problematic side effects, such as inflammation, bone pain, fever, and chill, and upon oral administration it is rapidly degraded, because it is composed of glycoproteins. Therefore, in order to solve these problems, there remains need for development of a low-molecular weight compound which exhibits G-CSF-like activity and which can serve as a substitute for G-CSF drugs. However, presently, very few compounds, such as those described in WO97/44033, are known to exhibit G-CSF-like activities.
Accordingly, an object of the present invention is to provide a novel low-molecular-weight compound exhibiting cytokine-like activities, particularly G-CSF-like activities.
Numerous studies have been carried out on imidazole compounds for possible application as agrochemicals or pharmaceuticals. Of the imidazole compounds, those having a 2-alkoxyphenyl group are reported in Japanese Patent Application Laid-Open (kokai) Nos. 63-146864 or 61-267557. However, these publications fail to mention whether or not those compounds exhibit cytokine-like activities. Moreover, a 2-alkoxyphenyl derivative having a halogen group at the 5-position of the phenyl group has not yet been reported.
DISCLOSURE OF THE INVENTION
Under the above circumstances, the present inventors performed screening tests on a variety of compounds, in search of low-molecular-weight compound having G-CSF-like activities, and have found that a novel class of imidazole derivatives (1) having a 2-alkoxy-5-halogenophenyl group exhibits cytokine-like activities; in particular, G-CSF-like activities, thus leading to completion of the invention.
The present invention provides an imidazole derivative represented by the following formula (1):
(wherein R
1
represents a lower alkyl group, R
2
represents an alkyl or aralkyl group, and X
1
represents a halogen atom) or a salt thereof, and an intermediate for the synthesis of the derivative or the salt.
The present invention also provides a drug containing an imidazole derivative of formula (1) or a salt thereof as an active ingredient.
The present invention also provides a pharmaceutical composition containing an imidazole derivative of formula (1) or a salt thereof, and a pharmacologically acceptable carrier.
The present invention also provides use of an imidazole derivative of formula (1) or a salt thereof in manufacture of a drug.
The present invention further provides a method of treating an immune disease accompanying reduction in neutrophils, the method comprising administration of an imidazole derivative of formula (1) to a patient in need thereof.
REFERENCES:
patent: 4432989 (1984-02-01), Spencer
patent: 4740601 (1988-04-01), Ogawa et al.
patent: 4894385 (1990-01-01), Kawamoto et al.
patent: 3907600 (1990-09-01), None
patent: 61-267557 (1986-11-01), None
patent: 63-146864 (1988-06-01), None
patent: 7-291936 (1995-11-01), None
patent: 97/44033 (1997-11-01), None
Eto Hiromichi
Kaneko Yasushi
Kusano Koji
Sato Susumu
Tachibana Koichi
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
SSP Co. Ltd.
Stockton Laura L.
LandOfFree
Imidazole derivatives or their salts does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole derivatives or their salts, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole derivatives or their salts will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3200691